Registration Dossier

Administrative data

Description of key information

Oral route: NOAEL males (28 d) > 86.9 mg/kg bw/day; female NOAEL (28 d) = 35.2 mg/kg bw/day).

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
NOAEL
35.2 mg/kg bw/day
Study duration:
subacute
Species:
rat

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

See attached document.

Justification for classification or non-classification

According to the CLP Regulation (EC 1272/2008), the substance is not classified for repeated dose toxicity. For justification see additional information.